Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Helus Pharma Inc.

NASDAQ: HELP · Life Sciences · 2 alerts · CIK 1833141

Share price
$7.67Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Helus Pharma Inc. filings on SEC EDGAR ↗

8:14 PM ET Form 4
Insider Buying

Helus Pharma CFO Greg Cavers Buys $38.7K of Stock

Greg Cavers, CFO, bought 3,000 shares of Helus Pharma Inc. at $12.91 a share, worth $38.7K in total on Sep 29, 2026. Shares held after the trade: 3,000.

Value
$38.7K
Shares
3,000
Price
$12.91
Role
CFO
Trade date
Sep 29, 2026
5:08 PM ET Form 4
Insider Buying

Cybin CEO Michael Halstead Buys $1.35M of Stock

Michael Halstead, CEO, bought 100,000 shares of Cybin Inc. at $13.47 a share, worth $1.35M in total on Sep 21, 2026. Shares held after the trade: 168,568 (+145.8%).

Value
$1.35M
Shares
100,000
Price
$13.47
Role
CEO
Holding change
+145.8%
Trade date
Sep 21, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.